These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29629897)

  • 1. Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension.
    Tamura Y; Phan C; Tu L; Le Hiress M; Thuillet R; Jutant EM; Fadel E; Savale L; Huertas A; Humbert M; Guignabert C
    J Clin Invest; 2018 May; 128(5):1956-1970. PubMed ID: 29629897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin, a Key Mediator Expressed by Senescent Pulmonary Vascular Cells in Pulmonary Hypertension.
    Saker M; Lipskaia L; Marcos E; Abid S; Parpaleix A; Houssaini A; Validire P; Girard P; Noureddine H; Boyer L; Vienney N; Amsellem V; Marguerit L; Maitre B; Derumeaux G; Dubois-Rande JL; Jourdan-Lesaux C; Delcroix M; Quarck R; Adnot S
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1879-90. PubMed ID: 27444202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
    Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
    Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resident cell lineages are preserved in pulmonary vascular remodeling.
    Crnkovic S; Marsh LM; El Agha E; Voswinckel R; Ghanim B; Klepetko W; Stacher-Priehse E; Olschewski H; Bloch W; Bellusci S; Olschewski A; Kwapiszewska G
    J Pathol; 2018 Apr; 244(4):485-498. PubMed ID: 29359814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
    Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin signalling system as a target for pulmonary arterial hypertension therapy.
    Huertas A; Tu L; Thuillet R; Le Hiress M; Phan C; Ricard N; Nadaud S; Fadel E; Humbert M; Guignabert C
    Eur Respir J; 2015 Apr; 45(4):1066-80. PubMed ID: 25745038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension.
    Stenmark KR; Frid MG; Graham BB; Tuder RM
    Cardiovasc Res; 2018 Mar; 114(4):551-564. PubMed ID: 29385432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
    Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodeling Matrix Synthesis in a Rat Model of Aortocaval Fistula and the Cyclic Stretch: Impaction in Pulmonary Arterial Hypertension-Congenital Heart Disease.
    Chang CJ; Huang CC; Chen PR; Lai YJ
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension.
    Papp R; Nagaraj C; Zabini D; Nagy BM; Lengyel M; Skofic Maurer D; Sharma N; Egemnazarov B; Kovacs G; Kwapiszewska G; Marsh LM; Hrzenjak A; Höfler G; Didiasova M; Wygrecka M; Sievers LK; Szucs P; Enyedi P; Ghanim B; Klepetko W; Olschewski H; Olschewski A
    Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 31023847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs.
    Zahid KR; Raza U; Chen J; Raj UJ; Gou D
    Cardiovasc Res; 2020 Oct; 116(12):1937-1947. PubMed ID: 32109276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension.
    Arnold ND; Pickworth JA; West LE; Dawson S; Carvalho JA; Casbolt H; Braithwaite AT; Iremonger J; Renshall L; Germaschewski V; McCourt M; Bland-Ward P; Kowash H; Hameed AG; Rothman AMK; Frid MG; Roger Thompson AA; Evans HR; Southwood M; Morrell NW; Crossman DC; Whyte MKB; Stenmark KR; Newman CM; Kiely DG; Francis SE; Lawrie A
    Nat Commun; 2019 Nov; 10(1):5183. PubMed ID: 31729368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension.
    Dai Z; Zhu MM; Peng Y; Jin H; Machireddy N; Qian Z; Zhang X; Zhao YY
    Am J Respir Crit Care Med; 2018 Sep; 198(6):788-802. PubMed ID: 29664678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction.
    Chen J; Wang YX; Dong MQ; Zhang B; Luo Y; Niu W; Li ZC
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism.
    Liu Y; Sun Z; Zhu J; Xiao B; Dong J; Li X
    J Cell Physiol; 2018 Jun; 233(6):4801-4814. PubMed ID: 29150946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Heterozygous
    Bohnen MS; Roman-Campos D; Terrenoire C; Jnani J; Sampson KJ; Chung WK; Kass RS
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28889099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.
    Sun M; Ramchandran R; Chen J; Yang Q; Raj JU
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):779-791. PubMed ID: 27438786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.